Erythromycin Ethylsuccinate 71209-0103
Product NDC
71209-0103- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 21, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216212
Need to source Erythromycin Ethylsuccinate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erythromycin Ethylsuccinate | 400 mg/5mL |
Drug Class
Decreased Sebaceous Gland Activity [PE]Macrolide Antimicrobial [EPC]Macrolide [EPC]
Packaging Options(1)
100 mL in 1 BOTTLE (71209-103-21)